Amarin Pharma, Inc. et al v. Roxane Laboratories, Inc. et.al,

Filing 166

ORDER that pending before the Court is ECF No. 165 Motion to modify the discovery plan and scheduling order. A response to be filed no later than 12/27/2018 and any reply be filed no later than 1/3/2019. Signed by Magistrate Judge Nancy J. Koppe on 12/20/2018. (Copies have been distributed pursuant to the NEF - KW)

1
2
3
4
5
6
7
UNITED STATES DISTRICT COURT
8
DISTRICT OF NEVADA
9
10

AMARIN PHARMA, INC., et al.,

Case No.: 2:16-cv-02525-MMD-NJK

Plaintiff,

11

Order

12

v.

13

HIKMA PHARMACEUTICALS USA INC.,
et al.,

14

[Docket No. 165]

Defendants.
15
16

Pending before the Court is Defendants’ motion to modify the discovery plan and

17 scheduling order, filed on an emergency basis. Docket No. 165. A response shall be filed no later
18 than December 27, 2018, and any reply shall be filed no later than January 3, 2019.
19

IT IS SO ORDERED.

20

Dated: December 20, 2018.

21

______________________________
Nancy J. Koppe
United States Magistrate Judge

22
23
24
25
26
27
28
1